Navigation Links
Palatin Announces Strategic Realignment of Operations
Date:9/24/2010

e safe harbors created thereby. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause Palatin's actual results to be materially different from its historical results or from any results expressed or implied by such forward-looking statements.  Palatin's actual results may differ materially from those discussed in the forward-looking statements for reasons including, but not limited to, results of clinical trials, regulatory actions by the FDA and the need for regulatory approvals, Palatin's ability to fund development of its technology and establish and successfully complete clinical trials, the length of time and cost required to complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products,  and other factors discussed in Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not responsible for updating for events that occur after the date of this press release.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies, Inc. to Raise $2.0 Million Dollars in Registered Direct Offering
2. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on February 16, 2010
3. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
4. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
5. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
6. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
7. Palatin Technologies to Present at the Rodman & Renshaw 11th Annual Global Investment Conference
8. Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering
9. Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration
10. Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
11. Palatin Technologies Listing Compliance Plan Accepted by NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... St Louis, MO (PRWEB) July 28, 2014 ... tools, software, and services that bring the power of ... for the inaugural Appistry Pipeline Challenge . ... Callum Bell, president of the National Center for Genome ... Children’s Mercy Hospitals and Clinics of Kansas City. Rounding ...
(Date:7/28/2014)... San Francisco, California (PRWEB) July 28, 2014 ... reach USD 604.40 billion by 2020, according to a ... scope coupled with the rising demand for effective vaccines ... to patients with unmet medical needs is expected to ... addition, the need to enhance agricultural productivity via the ...
(Date:7/28/2014)... Texas and COLLEGE STATION, Texas , ... hotel theatlashotel.com will be a 177-key, 4-star boutique ... in Bryan , Texas.  Photo ... As the first hotel within ATLAS ... include 177 rooms, a mixture of standard rooms and suites, a ...
(Date:7/28/2014)... The National Model Aviation Museum, located at the ... announce that it has been granted full civilian museum ... Air Force. , The certification is the culmination of ... with an on-site inspection by Sarah Sessions, Museum Certification ... National Museum of the United States Air Force , ...
Breaking Biology Technology:Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2
... (NYSE: SGP ) will provide a live ... Ph.D., executive vice president and president, Schering-Plough Research Institute, ... San Francisco on Monday, Jan. 12, at approximately 3:30 ... to talk about the company,s R&D pipeline and select ...
... 9 Endo Pharmaceuticals (Nasdaq: ENDP ) announced ... Endo, will present a corporate update at the J.P. Morgan ... 10:30 a.m. Pacific Time. The conference will be held ... live audio Webcast of the presentation may be accessed on ...
... Ireland, January 9 Azur Pharma Limited ... exclusive U.S. marketing rights,for Niravam(R) (alprazolam orally ... (baclofen,orally disintegrating tablets) and Fluxid(TM) (famotidine orally,disintegrating ... were not,disclosed. , ...
Cached Biology Technology:Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference 2Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB 2
(Date:7/25/2014)... Before the colonial era, 100,000s of people lived on ... cultures manipulated fire to control the availability of plants ... tribes continue to use fire to maintain desired habitat ... the U.S. Forest Service,s Pacific Southwest Station, will lead ... National Wildfire Refuge during the Ecological Society of America,s ...
(Date:7/25/2014)... study published online in the International Journal of ... to preventing cervical cancer based on findings showing successful ... of a discrete population of cells in the cervix. ... looked at squamocolumnar junction cells, or SCJ cells. These ... implicated as the origins of cervical cancer. A research ...
(Date:7/25/2014)... the way for the development of new lines of barley ... production is second only to wheat with 7-8 million tonnes ... diseases of barley. , Senior Research Scientist Dr Alan Little ... the cell walls of barley plants that block the penetration ... the ARC Centre of Excellence in Plant Cell Walls in ...
Breaking Biology News(10 mins):Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3Clearing cells to prevent cervical cancer 2New hope for powdery mildew resistant barley 2
... new role for a key cancer protein, a finding that ... variety of tumors. Many cancers are driven in part ... to escape growth controls and proliferate abnormally. In the new ... , researchers discovered that cyclin D1 also helps cancer cells ...
... by the Biotechnology and Biological Sciences Research Council (BBSRC)-led ... an enzyme in bacteria which could be used to ... in the 14 June Issue of the American Chemical ... out by teams at the Universities of Warwick and ...
... (June 9, 2011) − Mice born to mothers who are ... to develop intestinal tumors, report scientists at the Jean Mayer ... Tufts University. Previous research in humans and mice ... the prevention of colorectal cancer. Using a mouse model of ...
Cached Biology News:Cancer protein discovery may aid radiation therapy 2Cancer protein discovery may aid radiation therapy 3First wood-digesting enzyme found in bacteria could boost biofuel production 2B vitamins in mother's diet reduce colorectal cancer risk in offspring 2
... Proteolytic degradation is critical to the ... and regulatory proteins as important and ... metabolism, heat shock and stress response, ... receptors and ion channels, cell cycle ...
... standard for whole-blood clinical diagnostic work in ... less, this analyzer makes precise glucose measurements ... precise lactate measurements of whole blood, plasma, ... option allows you to have glucose results ...
... The first high-density serum biomarker chip to ... proteins. An antibody chip containing 120 human ... that enables biomarker discovery scientists to study ... benefits of therapy and the likelihood of ...
... description: The Costar strip ejector is a ... of Costar strips from their holder. Linkage: ... number, created to easily match Cornings product ... order under the old Sigma-Aldrich number (Z71,314-7) ...
Biology Products: